Navigation Links
US Oncology Network Recruits 1,000th Patient to Phase I Oncology Trials
Date:10/12/2010

ety concerns and other areas of interest and concern to keep patients safe and to find leads for efficacy that can move the trial to Phase II.

In 2005, when US Oncology's TOP program began, 26 patients were enrolled in Phase I trials across the country. The following year, 124 patients were enrolled in Phase I trials and the number has continued to grow. A record number of 260 patients are expected to be enrolled in Phase I trials through the US Oncology Research Network in 2010.

US Oncology Research Fact Sheet:

US Oncology Research is physician-led and physician-driven with a successful history of clinical depth and expertise.  

  • More than 43,000 patients have participated in more than 720 US Oncology Research trials.  
  • 1,000 have been enrolled in Phase I trials
  • In less than two decades, US Oncology Research has played a role in the development of 42 cancer therapies approved by the FDA.
  • The US Oncology Research network includes more than 90 practices in 200 locations across the U.S.
  • The network supports 12 sites that offer Phase I trials, including first-in-human trials.
  • At any given time, the network has more than 90 open clinical trials and more than 200 active trials.
  • Leadership at US Oncology Research consists of experts in a wide variety of cancer specialties including breast cancer, developmental therapeutics, gastrointestinal cancer, hematologic cancer, gynecologic cancer, genitourinary cancer, lung cancer, translational oncology program, and radiation therapy.
  • 58 manuscripts from investigator-initiated studies have been published in peer-reviewed journals.
  • US Oncology Research supports the nation's largest research network specializing in Phase I-IV oncology clinical trials. Investigator- and sponsor-initiated trials bring innovative therapies to patients in local communities across the nation.
  • To fi
    '/>"/>

SOURCE US Oncology, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. US Oncology Appoints Stephen Smith Vice President/General Manager Research and Personalized Science Services
2. MD Anderson Becomes a GeneGo Center of Excellence Using MetaCore for Oncology Research
3. US Oncology Pharmaceutical Distribution Service Wins National Safety Council Award
4. Expression Genetics EGEN-001 Named One of 10 Most Promising Oncology Products by Windhover
5. OncologySTAT Advisors Name Years Top Developments in Cancer Treatment and Research
6. First Coast Oncology to Offer Next Generation Proton Therapy
7. Radiation Therapy Oncology Group and US Oncology Enter Collaboration to Increase Patient Access to National Clinical Trials
8. Onyx Pharmaceuticals Licenses Rights to Novel Targeted Oncology Agent From BTG International
9. Debiopharm and Aurigene Sign Licensing Agreement for the Development and Commercialisation of Debio 0617, a Novel Inhibitor of an Undisclosed Oncology Pathway
10. Varian Medical Systems Introducing OncoView(TM) - an Oncology Specific Image Management and Storage Solution
11. Spectrum Pharmaceuticals and Cell Therapeutics to Jointly Market ZEVALIN, a Proprietary, Marketed Oncology Drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... James Sherley says he has been working towards ... since his days as a principal investigator at the Fox ... Sherley founded the ASCTC as a new Boston biotech ... property developed in Sherley’s research over the years since FCCC, ... (MIT), and more recently as a senior scientist at the ...
(Date:10/30/2014)... 30, 2014 Isis Pharmaceuticals, Inc. (NASDAQ: ... management will present a company overview at the Nomura Biotechnology ... in Boston, MA. A ... "Investors & Media" section of the Company,s website, www.isispharm.com ... within 48 hours and will be archived for a limited ...
(Date:10/27/2014)... 27, 2014 Ryan Carfley , Managing ... to sit down with Bryan Hamilton, the publisher of the ... discuss talent in the Research Triangle region of North Carolina. ... highlighted at the roundtable include the role of social ... of work/life balance and the unique role that Millennials play ...
(Date:10/27/2014)... The “Molecular Diagnostic Market by ... INAAT, DNA Sequencing), End User (Hospital, Laboratories), & ... Forecast to 2018” provides a detailed overview of ... trends, and strategies impacting the global molecular diagnostics ... the revenue and share analysis. , The global ...
Breaking Biology Technology:Boston’s Adult Stem Cell Technology Center, LLC Introduces A New Technology for Monitoring Previously Elusive Adult Stem Cells 2Boston’s Adult Stem Cell Technology Center, LLC Introduces A New Technology for Monitoring Previously Elusive Adult Stem Cells 3Boston’s Adult Stem Cell Technology Center, LLC Introduces A New Technology for Monitoring Previously Elusive Adult Stem Cells 4Isis Pharmaceuticals to Present at the Nomura Biotechnology Conference 2Personify's Ryan Carfley Talks Recruiting with Triangle Business Journal, RPG Solutions 2Personify's Ryan Carfley Talks Recruiting with Triangle Business Journal, RPG Solutions 3Global Molecular Diagnostics Market Will Reach $7.9 Billion by 2018 - New Research Report by MarketsandMarkets 2Global Molecular Diagnostics Market Will Reach $7.9 Billion by 2018 - New Research Report by MarketsandMarkets 3Global Molecular Diagnostics Market Will Reach $7.9 Billion by 2018 - New Research Report by MarketsandMarkets 4Global Molecular Diagnostics Market Will Reach $7.9 Billion by 2018 - New Research Report by MarketsandMarkets 5
... Bill Gates , Co-Chair and Trustee of the Bill & Melinda ... mobile technologies to improve health outcomes in the developing world at ... The summit, organized by the Foundation for the National Institutes of ... the mHealth Alliance, will be held November 8-10 in ...
... ROCKVILLE, Md. , Aug. 2 Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: ... and commercialization of products for central nervous system disorders, today announced it will ... 2010 , before the market opens. A full text copy of the release ... , , ...
... 2 Tengion Inc. (Nasdaq: TNGN ) ... the position of Chief Financial Officer.  Mr. Davis comes to Tengion after ... to develop improved protein therapeutics. At its peak, Neose employed 200 individuals, ... , , ...
Cached Biology Technology:Bill Gates Named Keynote Speaker at the 2010 mHealth Summit 2Bill Gates Named Keynote Speaker at the 2010 mHealth Summit 3Bill Gates Named Keynote Speaker at the 2010 mHealth Summit 4Vanda Pharmaceuticals to Announce Second Quarter 2010 Financial Results on August 5, 2010 2Tengion Appoints A. Brian Davis Chief Financial Officer 2
(Date:10/29/2014)... who lose their hair as a consequence of chemotherapy ... improve the scalp cooling technology that prevents hair loss. ... being pioneered by global scalp cooling manufacturing company, Paxman ... biology department of the University of Huddersfield. , The ... who has a background in the pharmacology of cancer ...
(Date:10/29/2014)... their food, but they also need protection from its harmful ... of molecules in plants that shields them from sun damage. ... American Chemical Society , one team reports on the mechanics ... and colleagues at Purdue University note that the harsh ultraviolet ... to plant DNA and, as a result, hinder plant growth. ...
(Date:10/29/2014)... German . ... Peter Schlögelhofer at the Max F. Perutz Laboratories (MFPL) ... of Vienna dived into the process of meiosis in ... an inversion of the standard meiotic phases. The researchers ... Nature Communications . , Meiosis is the two-step series ...
Breaking Biology News(10 mins):New technology on the way to aid cancer suffers who lose their hair after chemotherapy 2Meiotic cell division 'the other way round' 2
... Aluminum salts, or alum, have been injected into billions of ... one knows, however, how they boost the immune response. In ... the National Academy of Sciences researchers at National Jewish ... that host DNA coats the alum adjuvant and induces two ...
... N.C. -- The cost of complying with tougher EPA air-quality ... toward natural gas for electricity generation, according to a new ... particulate matter, nitrogen oxide and mercury may make nearly two-thirds ... as plants powered by natural gas, the study finds. ...
... Engineering Professor Tim Bender and Post-Doctoral Fellow Benoit ... polymer synthesis could have implications for the manufacture ... and even medical implants, the researchers say. ... subphthalocyanine polymers by facile coupling to poly (acrylic ...
Cached Biology News:Vaccine adjuvant uses host DNA to boost pathogen recognition 2Vaccine adjuvant uses host DNA to boost pathogen recognition 3New emissions standards would fuel shift from coal to natural gas 2Accidental discovery may lead to improved polymers 2
... agarose is used for second-dimension SDS-PAGE ... in place in PROTEAN Plus cells. ... to allow monitoring of electrophoresis runs. ... agarose in 1x Tris, glycine, SDS, ...
... HV high-voltage power supply, with temperature probe, 100-120 ... 5,000 V, 500 mA, and 400 W. The ... between 0 and 90 degrees C during electrophoresis. ... Power cord and instructions are provided. Dimensions are ...
The stirbar is used in the buffer tank of the Trans-Blot Plus cell to maintain uniform conductivity and temperature during electrophoretic transfer. Dimensions are 3.5 x 0.5 in....
... cooling coil, Trans-Blot cell, provides ... high-intensity, and extended electrophoretic transfer ... Trans-Blot cell. Use of the ... to an external water recirculator, ...
Biology Products: